Volume 10 (2012): Issue 8 (Aug 2012)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
NCCN News
Pages: xvi–xxi
Oncology Research Program
Pages: xxxiv–xxxvi
A Partnership Between the Academic and the Community
By: David P. Ryan
Pages: 919–921
Randomized Controlled Trials and 21st Century Epistemology
By: Frederic W. Grannis Jr
Pages: 926–927
Ten Years of Progress in Melanoma
By: John A. Thompson
Pages: 932–935
Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early-Stage Breast Cancer in a Young Woman With Li-Fraumeni Syndrome
By: Eve Henry, Victor Villalobos, Lynn Million, Kristin C. Jensen, Robert West, Kristen Ganjoo, Alexandra Lebensohn, James M. Ford, and Melinda L. Telli
Pages: 939–942
The First Documented Case of High-Grade Synovial Cell Sarcoma of the Rectum
By: Richard B. Hostetter, Min Yan, Houman Vaghefi, Kenneth Pennington, and Gary Cornette
Pages: 947–950
Soft Tissue Sarcoma, Version 2.2012
Featured Updates to the NCCN Guidelines
By: Margaret von Mehren, Robert S. Benjamin, Marilyn M. Bui, Ephraim S. Casper, Ernest U. Conrad III, Thomas F. DeLaney, Kristen N. Ganjoo, Suzanne George, Ricardo Gonzalez, Martin J. Heslin, John M. Kane III, Joel Mayerson, Sean V. McGarry, Christian Meyer, Richard J. O'Donnell, Benjamin Paz, John D. Pfeifer, Raphael E. Pollock, R. Lor Randall, Richard F. Riedel, Scott Schuetze, Karen D. Schupak, Herbert S. Schwartz, Sridhar Shankar, Brian A. Van Tine, Jeffrey Wayne, Hema Sundar, and Nicole R. McMillian
Pages: 951–960
Current Approaches in Hereditary Nonpolyposis Colorectal Cancer
By: Patrick M. Lynch
Pages: 961–967
Influential Factors for Post-Fellowship Career Decision-Making: An NCCN Survey
By: Jennifer L. Lyle, Jonathan L. Vandergrift, Jennifer M. Hinkel, Eva M. Lepisto, Kristie A. Cortazzo, Stephen Sherman, and F. Marc Stewart
Pages: 969–974
Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102)
By: Todd L. Demmy, Lin Gu, Jack E. Burkhalter, Eric M. Toloza, Thomas A. D'Amico, Susan Sutherland, Xiaofei Wang, Laura Archer, Linda J. Veit, Leslie Kohman, and the Cancer and Leukemia Group B
Pages: 975–982
Acute Myeloid Leukemia
By: Margaret R. O'Donnell, Camille N. Abboud, Jessica Altman, Frederick R. Appelbaum, Daniel A. Arber, Eyal Attar, Uma Borate, Steven E. Coutre, Lloyd E. Damon, Salil Goorha, Jeffrey Lancet, Lori J. Maness, Guido Marcucci, Michael M. Millenson, Joseph O. Moore, Farhad Ravandi, Paul J. Shami, B. Douglas Smith, Richard M. Stone, Stephen A. Strickland, Martin S. Tallman, Eunice S. Wang, Maoko Naganuma, and Kristina M. Gregory
Pages: 984–1021
Who Benefits From Maintenance Therapy in Acute Promyelocytic Leukemia?
By: Edmond Marzbani and Elihu Estey
Pages: 1023–1028
Monitoring Minimal Residual Disease in Acute Myeloid Leukemia: Ready for Prime Time?
By: Farhad Ravandi and Jeffrey L. Jorgensen
Pages: 1029–1036
Managing the Financial Impact of Cancer Treatment: The Role of Clinical Practice Guidelines
By: Scott Ramsey and Veena Shankaran
Pages: 1037–1042
  • Collapse
  • Expand